Hepatorenal failure with self-initiated intermittent rifampicin therapy

Rothwell, D L; Richmond, D E
June 1974
British Medical Journal;6/1/1974, Vol. 2 Issue 5917, p481
Academic Journal
No abstract available.


Related Articles

  • Acute Hemolysis and Oligoanuric Acute Renal Failure Caused by Interrupted. Yanardag, Halil // Internet Journal of Nephrology;2005, Vol. 2 Issue 1, p36 

    A 38-year-old patient was treated with relapsing pulmonary tuberculosis with reinstitution of rifampicin (RFP) after a medication-free interval of l8 years. One week after initiation of treatment the patient developed acute severe hemolytic anemia and oligoanuric acute renal failure (ARF)...

  • Acute rifampicin-associated interstitial tubulopathy in a patient with pulmonary tuberculosis: a case report. Rosati, Silvia; Cherubini, Chiara; Iacomi, Fabio; Giannakakis, Konstantinos; Vincenzi, Laura; Ippolito, Giuseppe; Palmieri, Fabrizio // Journal of Medical Case Reports;2013, Vol. 7 Issue 1, p1 

    Introduction: Rifampicin is one of the most effective antibiotics for treating tuberculosis, but it has been associated with adverse reactions, such as nephrotoxicity, sometimes resulting in acute renal failure with oligoanuria, and hepatotoxicity. Although deterioration of renal function,...

  • Hepatorenal syndrome precipitated by infective endocarditis. Patel, Peysh A.; Lowe, Emma; Baig, Wazir; Sandoe, Jonathan // British Journal of Hospital Medicine (17508460);Sep2011, Vol. 72 Issue 9, p532 

    The article discusses a case study of a 67-year old man who presented to the emergency department (ED) with intermittent pyrexia, rigors and weight loss, and a history of sepsis and liver cirrhosis. He was started on vancomycin and rifampicin after blood culture was positive for Staphylococcus...

  • Zespół wÄ…trobowo-nerkowy - współczesne możliwoÅ›ci terapeutyczne. Madej, Grzegorz; Simon, Krzysztof; Łabędzka, Hanna; Czajkowska, Magdalena; Czerwony, Marcin // Gastroenterologia Polska / Gastroenterology;2008, Vol. 15 Issue 3, p191 

    Hepatorenal syndrome is a specific renal failure that occurs in patients with end-stage liver disease in absence of any identifiable renal pathologies. Hepatorenal syndrome is caused by hypoperfusion of the kidney which is a result of fluid redistribution between compartments and relative...

  • Hepatorenal Syndrome: A Dreaded Complication of End-Stage Liver Disease. Cárdenas, Andrés // American Journal of Gastroenterology;Feb2005, Vol. 100 Issue 2, p460 

    Hepatorenal syndrome is the dreaded complication of end-stage liver disease characterized by functional renal failure due to renal vasoconstriction in the absence of underlying kidney pathology. The pathogenesis of hepatorenal syndrome is the result of an extreme underfilling of the arterial...

  • Continuous renal replacement therapy versus intermittent hemodialysis in acute renal failure. Cuhaci, Bulent // Kidney International;Apr2002, Vol. 61 Issue 4, p1548 

    Comments on R.L. Mehta et al's article 'A randomized clinical trial of continuous versus intermittent dialysis for acute renal failure.' Disadvantages of continuous renal replacement therapy; Advantages of intermittent hemodialysis.

  • A boy undergoing maintenance hemodialysis who developed mediastinal lymph node tuberculosis. Okada, Mitsuru; Sugimoto, Keisuke; Yagi, Kazuro; Yanagida, Hidehiko; Tabata, Nobutada; Takemura, Tsukasa // Clinical & Experimental Nephrology;Jun2006, Vol. 10 Issue 2, p152 

    The incidence of tuberculosis (TBC) in patients undergoing maintenance hemodialysis is reported to be higher than that in the general population. We report an 8-year-old boy receiving such treatment for chronic renal failure who developed mediastinal lymph node TBC. He showed only intermittent...

  • hepatorenal syndrome.  // Taber's Cyclopedic Medical Dictionary (2009);2009, Issue 21, p1063 

    An encyclopedia entry for "hepatorenal syndrome," which refers to renal failure caused by abnormal kidney perfusion, is presented.

  • Erlotinib.  // Reactions Weekly;11/20/2010, Issue 1328, p20 

    The article describes the case of a man with pancreatic cancer who developed liver failure and hepatorenal syndrome while receiving treatment with erlotinib.

  • Antiretroviral Therapy in Children with Tuberculosis: Progress toward Defining the Issues. Cotton, Mark F.; Rabie, Helena; van Zyl, Gert U. // Journal of Infectious Diseases;4/15/2010, Vol. 201 Issue 8, p1113 

    The authors reflect on the study that evaluates the effectiveness of antiretroviral therapy in children with tuberculosis. They contend that children cotreated for tuberculosis had significantly poorer virological outcomes due to factors such as failure to thrive and respiratory symptoms. The...


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics